HighVista Strategies’s Filana Therapeutics FLNA Stock Holding History

HighVista Strategies’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,488	Closed	-$212K	–	140
2021 Q2	$212K	Buy	+2,488	New	+$133K	0.15%	75

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HighVista Strategies's FLNA Position: Q3 2021 in Review

HighVista Strategies sold out of Filana Therapeutics (FLNA) in Q3 2021, closing a stake of 2,488 shares — an estimated $212K sold.

HighVista Strategies first reported a position in FLNA in Q2 2021 and held it in 1 quarter. The position peaked at $212K in Q2 2021. 180 funds tracked by Wall St. Rank hold FLNA as of Q3 2021.

HighVista Strategies reported no remaining Filana Therapeutics position as of Q3 2021 after selling out during the quarter.
HighVista Strategies sold 2,488 Filana Therapeutics shares in Q3 2021, an estimated $212K.
HighVista Strategies first reported a position in Filana Therapeutics in Q2 2021 and held it in 1 quarter.
HighVista Strategies's Filana Therapeutics position peaked at $212K in Q2 2021.
180 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2021.

Based on HighVista Strategies's 13F filing for Q3 2021, filed 15 Nov 2021.